Emergent Biosolutions Competitors and Similar CompaniesClear all
Emergent Biosolutions's competitors and similar companies include Valneva and Teva Pharmaceuticals.
 Emergent Biosolutions Emergent Biosolutions is a biopharmaceutical company that provides vaccines and therapeutics against public health threats. |  Valneva Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases. | ||
Founding Date | Founding Date 1998 | Founding Date 2013 | Founding Date 1901 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Gaithersburg, US HQ Mississauga, CA Winnipeg, CA Dublin, IE London, GB Canton, US Lansing, US see more | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more | |
Employees | Employees 90044% decrease | Employees 713 | Employees 37,000 |
Valuation ($) | Valuation ($) 493.6 m | Valuation ($) 482.5 m | Valuation ($) 20.8 b |
Financial | |||
Revenue (est.) | Revenue (est.) $742.9m (FY, 2025) | Revenue (est.) €157.9m (FY, 2025) | Revenue (est.) $17.3b (FY, 2025) |
Cost of goods | Cost of goods $326.2m (FY, 2025) | Cost of goods €8.2m (FY, 2025) | Cost of goods $8.3b (FY, 2025) |
Gross profit | Gross profit $416.7m (FY, 2025) | Gross profit €177.7m (FY, 2025) | Gross profit $8.9b (FY, 2025) |
Net income | Net income $52.6m (FY, 2025) | Net income (€115.2m) (FY, 2025) | Net income $1.4b (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 34.5m | Total funding raised $ 51.7m | Total funding raised $ 358m |
For sources of this data, please see the company profile
View Company Profiles
Valneva
HQ
Saint-Herblain, FR
Employees
713
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases.
View company
Teva Pharmaceuticals
HQ
Petah Tikva, IL
Employees
37,000
Teva Pharmaceuticals is a global pharmaceutical company.
View company